Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

The global fragile X syndrome market is witnessing significant growth, propelled by increasing awareness of genetic disorders and advancements in diagnostic and therapeutic technologies. fragile X syn...

The Cannabis Use Disorder Market was valued at in and is anticipated to reach by , at a CAGR of 0.09 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...

Rett Syndrome is a rare, genetic neurological disorder that primarily affects girls and leads to severe cognitive, motor, and communicative impairments. It is most caused by mutations in the MECP2 gen...

According to Stratistics MRC, the Global Neurodegenerative Disease Market is accounted for $64.4 billion in 2025 and is expected to reach $118.9 billion by 2032 growing at a CAGR of 9.15% during the f...

The Alzheimer'S Drugs Market is valued at USD 8.4 billion in 2025 and is projected to grow at a CAGR of 9.3% to reach USD 18.7 billion by 2034.The Alzheimer’s Drugs Market is a key segment of the broa...

The Alzheimer’S Disease Treatment Market is valued at USD 8.7 billion in 2025 and is projected to grow at a CAGR of 8.1% to reach USD 17.6 billion by 2034.The Alzheimer’s Disease Treatment Market is w...

The Antidepressants Market is valued at USD 14.8 billion in 2025 and is projected to grow at a CAGR of 4.4% to reach USD 21.9 billion by 2034.The Antidepressants Market focuses on the development and...

The Benzodiazepine Drugs Market is valued at USD 4.5 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 8.5 billion by 2034.The benzodiazepine drugs market remains a critical comp...

The Anti-Parkinson Drugs Market is valued at USD 9.4 billion in 2025 and is projected to grow at a CAGR of 7.3% to reach USD 17.7 billion by 2034.The Anti-Parkinson Drugs Market focuses on medications...

The Attention Deficit Hyperactivity Disorder (Adhd) Therapeutics Market is valued at USD 12.7 billion in 2025 and is projected to grow at a CAGR of 7% to reach USD 23.3 billion by 2034. Attention Defi...

The Epilepsy Drugs Market is valued at USD 9.1 billion in 2025 and is projected to grow at a CAGR of 8.1% to reach USD 18.4 billion by 2034. Epilepsy Drugs Market Overview The global epilepsy drugs ma...

The Fentanyl Market is valued at USD 14.6 billion in 2025 and is projected to grow at a CAGR of 7.3% to reach USD 27.5 billion by 2034. Fentanyl Market Overview The fentanyl market has experienced sig...

The Generic Central Nervous System Drugs Market is valued at USD 78.4 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 149.7 billion by 2034. Generic Central Nervous System Drug...

The Grand Mal Seizure Treatment Market is valued at USD 2.7 billion in 2025 and is projected to grow at a CAGR of 5.2% to reach USD 4.2 billion by 2034. Grand Mal Seizure Treatment Market Overview The...

The Headache Disorders Market is valued at USD 6 billion in 2025 and is projected to grow at a CAGR of 6.6% to reach USD 10.7 billion by 2034.The headache disorders market continues to gain prominence...

The Opioid Use Disorder (Oud) Market is valued at USD 5.3 billion in 2025 and is projected to grow at a CAGR of 10.6% to reach USD 13.1 billion by 2034.The opioid use disorder (OUD) market is witnessi...

The Oxycodone Drugs Market is valued at USD 7.5 billion in 2025 and is projected to grow at a CAGR of 7.6% to reach USD 14.5 billion by 2034.The oxycodone drugs market remains a critical segment of th...

The Sedative-Hypnotic Drugs Market is valued at USD 4.8 billion in 2025 and is projected to grow at a CAGR of 7.6% to reach USD 9.3 billion by 2034.The Sedative-Hypnotic Drugs market includes medicati...

The Global Parkinson’s Disease Therapeutics Market was valued at US$ 5.92 Billion in 2024 and is anticipated to reach US$ 12.83 Billion by 2033, at a CAGR of 0.081 from 2026 to 2032. The report delive...

The Alzheimer Drugs Market was valued at US$ 4.46 billion in 2023 and is anticipated to reach US$ 18.33 billion by 2031, at a CAGR of 0.194 from 2026 to 2032. The report delivers in-depth insights int...

The Global Narcolepsy Therapeutics Market was valued at US$ 2.93 billion in 2023 and is anticipated to reach US$ 6.98 billion by 2033, at a CAGR of 0.091 from 2026 to 2032. The report delivers in-dept...

... the growth prospects of global Mental Illness Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Mental Illness Drugs market by product type, application ...

... being 2017) and the growth prospects of global Neuroprotective Drugs market for 2018-2023. Neuroprotective Drugs consist of medications that can ... the structure of Neuroprotective Drugs market by identifying its various subsegments. Focuses on the key global Neuroprotective Drugs manufacturers, to define ...

... 2017) and the growth prospects of global Neuroprotective Products market for 2018-2023. Neuroprotective Products consist of medications that ... report presents a comprehensive overview, market shares, and growth opportunities of Neuroprotective Products market by product type, application, key manufacturers and ...

... global market share (sales and revenue) of key companies in Cyclobenzaprine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Cyclobenzaprine market ... data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Purity ...

... global market share (sales and revenue) of key companies in Fampridine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Fampridine market ... breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Purity:95% ...

... global market share (sales and revenue) of key companies in Lamotrigine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Lamotrigine market ... data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Purity:98%-99% ...

... global market share (sales and revenue) of key companies in Levetiracetam business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Levetiracetam market ... data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Purity:98% ...

... the global market share (sales and revenue) of key companies in Paroxetine Hydrochloride business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Paroxetine Hydrochloride market ...

... the global market share (sales and revenue) of key companies in Tramadol Hydrochloride business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Tramadol Hydrochloride market ...

According to this study, the global Cognitive and Memory Enhancer Drugs market size will reach US$ 6424 million by 2031. Cognitive enhancers are drugs and supplements, which are majorly used to treat...

According to this study, the global Chronic Depressive Personality Disorder Treatment market size will reach US$ million by 2031. Chronic depressive personality disorder also known as Dysthymia is a c...

The global Entacapone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff mea...

The global Dopamine Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...

The global Fluvoxamine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff me...

The global Hypnotics and Sedatives market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U....

The global Opioid Anesthetics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. ta...

The global Schizophrenia Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...

According to this study, the global Visceral Pain market size will reach US$ 1385 million by 2031. Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abd...

The global Huntington's Disease Therapeutics market size is predicted to grow from US$ 472 million in 2025 to US$ 2373 million in 2031; it is expected to grow at a CAGR of 30.9% from 2025 to 2031. The...

The global Bipolar Disorder Therapeutic market size is predicted to grow from US$ 3996 million in 2025 to US$ 4527 million in 2031; it is expected to grow at a CAGR of 2.1% from 2025 to 2031. The impa...

The global Tourette Syndrome Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S...

According to this study, the global Parkinson's Disease Treatments market size will reach US$ million by 2031. Parkinson’s disease is a central nervous system syndrome which affects the motor neuron,...

The global Metachromatic Leukodystrophy (MLD) Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The im...

The global GABA Receptor Agonist Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...

The global Canavan Disease Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the late...

The global Alzheimer’s Therapeutic market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U....

The global Anti-Suicide Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tar...

According to this study, the global Acute Ischemic Stroke Therapeutics market size will reach US$ million by 2031. AIS is a chronic condition characterized by the sudden loss of blood supply to a part...

The global Anxiety and Panic Disorders Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the...